Canadian application, no grantCanada
Wound care compositions
CA 2507956 A1 · Owner: Kimberly-Clark Worldwide, Inc. · Inventors: Quirk, Stephen
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides polypeptides that can inhibit the activity of matrix metalloproteinases. Such polypeptides are useful for treating wounds for , example, chronic wounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 18, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 18, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 18, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 18, 2003
GrantedNo grant recorded
Term endedNovember 18, 2023
Patent numberCA 2507956 A1
Classification (IPC)C12N15/15 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.